Sign In
Buy TMDX
$76.51
+0.380 (+0.499%)
At Close: Jul 31, 2026
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026
04:05pm, Tuesday, 21'st Apr 2026
ANDOVER, Mass., April 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics Group (NASDAQ:TMDX) Shares Up 8.5% – Here’s What Happened
03:58am, Sunday, 19'th Apr 2026
TransMedics Group, Inc. (NASDAQ: TMDX - Get Free Report)'s share price shot up 8.5% during trading on Friday. The stock traded as high as $117.00 and last traded at $118.4260. 171,261 shares traded ha
2 Healthcare Stocks That Could Outperform the Market Over the Next Decade
06:00pm, Thursday, 16'th Apr 2026
TransMedics Group's innovative approach could help it capture a larger share of the organ transplant market. Dexcom still has vast untapped opportunities in its niche.
A Look at TransMedics Group Inc (TMDX) After 4.4% Gain -- GF Value $177.87 vs Price $114.00
05:53pm, Friday, 10'th Apr 2026
On April 10, 2026, TransMedics Group Inc (TMDX) shares rose 4.4% today, bringing the current price to $114.00. The stock has exhibited a 52-week range of $72.78
SG Americas Securities LLC Purchases 8,762 Shares of TransMedics Group, Inc. $TMDX
04:59am, Monday, 06'th Apr 2026
SG Americas Securities LLC grew its position in TransMedics Group, Inc. (NASDAQ: TMDX) by 125.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Critical Survey: TransMedics Group (NASDAQ:TMDX) vs. WORK Medical Technology Group (NASDAQ:WOK)
01:35am, Sunday, 05'th Apr 2026
TransMedics Group (NASDAQ: TMDX - Get Free Report) and WORK Medical Technology Group (NASDAQ: WOK - Get Free Report) are both medical companies, but which is the better investment? We will contrast th
TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?
12:32pm, Thursday, 26'th Mar 2026
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?
Reasons to Retain TransMedics Stock in Your Portfolio for Now
11:36am, Wednesday, 25'th Mar 2026
TMDX rides OCS adoption and strong fourth-quarter results, but margin pressure raises questions for investors.
TransMedics Group (NASDAQ:TMDX) & Disaboom (OTCMKTS:MEDH) Head-To-Head Survey
01:10am, Wednesday, 25'th Mar 2026
Disaboom (OTCMKTS:MEDH - Get Free Report) and TransMedics Group (NASDAQ: TMDX - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push
06:17am, Monday, 23'rd Mar 2026
TransMedics Group (NASDAQ: TMDX) CEO Waleed Hassanein and CFO Gerardo Hernandez-Omana provided updates on the company's strategy, clinical trial planning, and operational initiatives during a fireside
TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven
04:30am, Monday, 16'th Mar 2026
TransMedics is positioned for accelerating growth, with revenue expected to expand around 25% in 2026 and free cash flow breakeven by late 2026 or early 2027. TMDX is over the crest of its capex cycle
TransMedics Group, Inc. $TMDX Position Increased by ArrowMark Colorado Holdings LLC
03:52am, Sunday, 15'th Mar 2026
ArrowMark Colorado Holdings LLC boosted its stake in shares of TransMedics Group, Inc. (NASDAQ: TMDX) by 54.0% in the third quarter, according to its most recent filing with the Securities and Exchang
TransMedics: Numb Reaction To Extraordinary Fundamentals
10:20am, Monday, 09'th Mar 2026
TransMedics has transitioned into a fundamentally strong, profitable growth story with reduced volatility and clear operational leverage. TMDX delivered a robust Q4, exceeding revenue and earnings est
Royce Small-Cap Fund FY 2025: What Worked
03:55am, Monday, 09'th Mar 2026
Five of the Fund's 10 equity sectors made a positive impact on calendar year performance, led by Industrials, Financials, and Information Technology. Alamos Gold's positive earnings outlook, a renewed
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026?
05:22am, Sunday, 08'th Mar 2026
TransMedics remains the top dog in its industry and may have a widening moat. The founder-led company's shares have risen eightfold since 2019.
